InsidersTradesSigma
申报总数
公司
▲ 买入（5 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
5
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Klemp Walter V, 董事长兼首席执行官. Director active across 3 companies, notably Moleculin Biotech, Inc.. Aggregated, 29 filings have been logged. Split: 5 buys · 0 sell. Total volume traded: €278k. History available since 16 December 2021. The latest transaction was filed on 26 December 2023 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Klemp Walter V
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报29 总计
13,000 股Common StockSEC:0001437749-26-029835:0
533,333 股Common StockSEC:0001437749-26-025928:0
标准退出：2026年11月1日 (T+90)
150 股Common StockSEC:0001437749-26-021611:0
37 股Common StockSEC:0001437749-26-021611:1
360 股Common StockSEC:0001437749-26-021611:2
88 股Common StockSEC:0001437749-26-021611:3
28,750 股Common StockSEC:0001437749-25-033683:0
3,750 股Common StockSEC:0001437749-25-021050:0
1,667 股Common StockSEC:0001437749-25-020802:0
982 股Common StockSEC:0001437749-24-022252:0
8,990 股Common StockSEC:0001437749-24-021197:0
3,750 股Common StockSEC:0001437749-24-020995:0
1,667 股Common StockSEC:0001437749-24-020663:0
188,404 股@ US$0.6942.4% 占其流量Common StockSEC:0001437749-23-035340:0
标准退出：2024年3月25日 (T+90)
13,204 股Common StockSEC:0001437749-23-019907:0
14,717 股Common StockSEC:0001437749-23-019412:0
56,250 股Common StockSEC:0001437749-23-018140:0
25,000 股Common StockSEC:0001437749-23-017884:0
45,000 股@ US$1.280719.9% 占其流量Common StockSEC:0001437749-22-028116:0
标准退出：2023年2月23日 (T+90)
22,500 股@ US$1.14969.0% 占其流量Common StockSEC:0001437749-22-027949:0
标准退出：2023年2月19日 (T+90)
85,213 股@ US$0.969528.7% 占其流量Common StockSEC:0001437749-22-027792:0
标准退出：2023年2月14日 (T+90)
14,717 股Common StockSEC:0001437749-22-017220:0
13,204 股Common StockSEC:0001437749-22-017219:0
13,204 股Common StockSEC:0001437749-22-017075:0
14,717 股Common StockSEC:0001437749-22-016754:0
29 条申报中的 25 条
About Klemp Walter V
KLEMP WALTER V is Président-Directeur Général. He is linked to Moleculin Biotech, Inc., where he is CEO and President, and to Soliton, Inc., where he is Executive Chairman. He has made 27 filings in total, and, across the recent sampled filings held, buy amounts are 278132 EUR and sell amounts are 8506957 EUR, with filings ranging from 2021-07-06 to 2026-06-24.
